Steady progress in the scaleup of VMMC as an HIV prevention intervention in 15 eastern and southern African countries before the SARS-CoV2 pandemic
Introduction
Accessed 02.03.2020
The Global Prevalence of Male Circumcision
Accessed: 02.03.2020
WHO Progress Brief
Progress Brief
July 2017
An Addendum to Sexual and Reproductive Health (SRH) Policy Guidelines and Service Standards
Public Report
PQMC 0001-001-04 WHO PQMC Public Report November/2016, version 8.0
Health Benefits and Associated Risks
Accessed: 02.03.2020
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...ls in the Democratic Republic of the Congo between August 2005 and September 2009 to support the registration of pafuramidine for treatment of first stage HAT in collaboration with the United States Food and Drug Administration. Patients were treated with either 100 mg of pafuramidine orally twice a day for 10 days or 4 mg/kg pentamidine intramuscularly once daily for 7 days to assess the efficacy and safety of pafuramidine versus pentamidine. Pregnant and lactating women as well as adolescents were included.
more
Version 2, updated 17 March 2016